{"title":"BUPROPION INDUCED DELAYED ONSET URTICARIA: A CASE REPORT","authors":"Sriparna Bhattacharyya, Suresh Chakravarty","doi":"10.36106/ijar/6103235","DOIUrl":null,"url":null,"abstract":"Bupropion is an oral antidepressant which acts by inhibiting the reuptake of dopamine and noradrenaline from synapse.\nApart from treatment of depressive disorders, it is used off-label for smoking cessation, treatment of attention-decit\nhyperactivity disorder and obesity. Bupropion is generally well-tolerated and has a favorable safety prole. Till date there have only been few case\nreports of allergic skin reactions associated with bupropion. Apart from being a rare adverse reaction, the unique feature of delayed onset of\nallergic reaction may lead to underreporting of the phenomenon. Here we present a case report of a 30 years old male who presented with\ngeneralized urticaria after twenty-three days of bupropion initiation. This report serves to promote awareness among the clinicians about the\nassociation of delayed-onset allergic phenomenon with use of Bupropion.","PeriodicalId":13502,"journal":{"name":"Indian journal of applied research","volume":"47 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of applied research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36106/ijar/6103235","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Bupropion is an oral antidepressant which acts by inhibiting the reuptake of dopamine and noradrenaline from synapse.
Apart from treatment of depressive disorders, it is used off-label for smoking cessation, treatment of attention-decit
hyperactivity disorder and obesity. Bupropion is generally well-tolerated and has a favorable safety prole. Till date there have only been few case
reports of allergic skin reactions associated with bupropion. Apart from being a rare adverse reaction, the unique feature of delayed onset of
allergic reaction may lead to underreporting of the phenomenon. Here we present a case report of a 30 years old male who presented with
generalized urticaria after twenty-three days of bupropion initiation. This report serves to promote awareness among the clinicians about the
association of delayed-onset allergic phenomenon with use of Bupropion.